HealthQuill Gene Editing
AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in oncology, immunology and rare diseases.
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.

Read More
US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria.
Drugs Health Pharma

Gene editing kills female mosquitoes that spread malaria

HQ Team July 10, 2023: US researchers have genetically edited mosquitoes to kill females of the species responsible for the spread of malaria..

Read More
gene editing
Drugs Health Medical Pharma

FDA considering approval for first ever CRISPR gene editing technology drug

HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.

Read More
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.
Drugs Medical Pharma

‘Love hormone’ Oxytocin breaks a three-decade-old perception

The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for.

Read More